Jad Chahoud, MD, MPH, MHA, is a genitourinary medical oncologist at Moffitt Cancer Center in Tampa, Florida.
Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
The combination of zanzalintinib plus nivolumab demonstrated encouraging preliminary activity with manageable safety.
Jad Chahoud, MD, on the phase 1b STELLAR-002 trial in ccRCC
Jad Chahoud, MD, MPH, MHA, discusses the mechanism of action for zanzalintinib and walks through key design elements of the STELLAR-002 trial.
FDA news recap in urology for Q2 2025
da Vinci 5 Surgical System approved in Europe
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC